Abbas G, Silveira MG, Lindor KD (2011) Hepatic fibrosis and the reninangiotensin system. Am J Ther 18(6):202–208

Article  Google Scholar 

Abdelzaher MA, Ibrahim AS, Negm EM (2021) Increasing fetal hemoglobin as a possible key for improvement of hypoxia and saving last breath in COVID-19 patient: “postulating a hypothesis”. Egypt J Bronchol 15(1):33

Article  Google Scholar 

Afify S, Eysa B, Hamid FA et al (2021) Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 27(42):7362–7375

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albadawy RM, Jadoon BA, Mogahed MM et al (2021) The impact of comorbidities on the outcomes of Egyptian COVID-19 patients: a follow-up study. J Environ Public Health:6662476. https://doi.org/10.1155/2021/6662476

Armstrong RA, Kane AD, Cook TM (2020) Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia 75(10):1340–1349

Article  CAS  PubMed  Google Scholar 

Blagosklonny MV (2020) From causes of aging to death from COVID-19. Aging 12(11):10004–10021

Article  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control Prevention (2012) Progress toward prevention and control of hepatitis C virus infection—Egypt, 2001–2012. MMWR Morb Mortal Wkly Rep 61(29):545

Google Scholar 

Cerbu B, Pantea S, Bratosin F et al (2021) Liver impairment and hematological changes in patients with chronic hepatitis C and COVID-19: a retrospective study after one year of pandemic. Medicina (Kaunas) 57(6):597

Article  PubMed  Google Scholar 

Czick M, Shapter C, Shapter R (2020) COVID's razor: RAS imbalance, the common denominator across disparate, unexpected aspects of COVID-19. Diabetes Metab Syndr Obes 13:3169–3192

Article  CAS  PubMed  PubMed Central  Google Scholar 

Des Jarlais DC, Cooper HLF, Arasteh K, Feelemyer J, McKnight C, Ross Z (2018) Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011–2015, with implications for the current opioid epidemic in the US. PLoS One. 13:e0194799

Article  CAS  PubMed  PubMed Central  Google Scholar 

el Gohary A, Hassan A, Nooman Z et al (1995) High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 59(2):155–161

Article  PubMed  Google Scholar 

Emam M, Radwan MI, Refaey MM, Shaheen NE, Abd-ElMoez S, Gerges MA (2015) Prevalence of hepatitis C virus in an elderly population in rural areas of Sharkia governorate, Egypt. Egypt Liver J 5(2):29–33

Article  Google Scholar 

Emami A, Javanmardi F, Pirbonyeh N, Akbari A (2020) Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med 8(1):35

Google Scholar 

Fouad SH, Allam MF, Ibrahim S et al (2021) ICU admission of COVID-19 patients: identification of risk factors. Egypt J Anaesth 37(1):202–207

Article  Google Scholar 

Ghweil AA, Hassan MH, Khodeary A et al (2020) Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA Quarantine Hospital’s patients, Egypt: a retrospective study. Infect Drug Resist 13:2375–2383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grasselli G, Greco M, Zanella A et al (2020a) Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 180(10):1345–1355

Article  CAS  PubMed  Google Scholar 

Grasselli G, Zangrillo A, Zanella A et al (2020b) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323(16):1574–1581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720

Article  CAS  PubMed  Google Scholar 

Hafez MZE, Nassar AY, Nassar GAY (2021) Epidemiology of Coronavirus Disease (COVID-19) in Assiut Province in Egypt. AJRID 6(2):19–25

Article  Google Scholar 

IBM SPSS (2020) Statistics for Windows, Version 27. IBM Corp., Armonk. [cited 2021 Oct 24]. Available from: https://www-01.ibm.com/support/docview.wss?uid=swg27049428

Jassat W, Cohen C, Tempia S et al (2021) Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV 8(9):554–567

Article  Google Scholar 

Jin JM, Bai P, He W et al (2020) Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 8:152. https://doi.org/10.3389/fpubh.2020.00152

Article  PubMed  PubMed Central  Google Scholar 

Khamiss AM, El-Dahshan M, El-Ghamery F, Aggag M, Hashim A, Eliwa A (2021) Outcomes of COVID-19 in Egyptian patients. Al-Azhar. Med. J 50(1):765–782

Google Scholar 

Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ (2018) Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci Rep 8(1):1661

Article  PubMed  PubMed Central  Google Scholar 

Kulkarni AV, Kumar P, Tevethia HV et al (2020) Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther 52(4):584–599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin L, Li TS (2020) Interpretation of guidelines for the diagnosis and treatment of novel coronavirus (2019- nCoV) infection by the National Health Commission (Trial Version 5). Zhonghua Yi Xue Za Zhi 100:E001. https://doi.org/10.3760/cma.j.issn.0376-2491.2020.0001

Article  CAS  PubMed  Google Scholar 

Mak KY, Chin R, Cunningham SC et al (2015) ACE2 therapy using adeno-associated viral vector inhibits liver fibrosis in mice. Mol Ther 23(9):1434–1443

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mallet V, Beeker N, Bouam S, Sogni P, Pol S, Demosthenes research group (2021) Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. J Hepatol. 75(4):848–855. https://doi.org/10.1016/j.jhep.2021.04.052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangia A, Cenderello G, Verucchi G et al (2020) Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis? World J Clin Cases 8(22):5831–5834

Article  PubMed  PubMed Central  Google Scholar 

Nassar Y, Mokhtar A, Elhadidy A et al (2021) Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study. J Infect Public Health 14:1381–1388

Article  PubMed  PubMed Central  Google Scholar 

Negm EM (2022) Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”. Egypt J Bronchol 16:19

Article  Google Scholar 

Ni W, Yang X, Yang D et al (2020) Role of angiotensin-converting enzyme 2 ( ACE2 ) in COVID-19. Crit Care 24(1):422. https://doi.org/10.1186/s13054-020-03120-0

Article  PubMed  PubMed Central  Google Scholar 

Oarhe CI, Dang V, Dang M et al (2015) Hyperoxia downregulates angiotensin-converting enzyme-2 in human fetal lung fibroblasts. Pediatr Res 77(5):656–662

Article  CAS  PubMed  PubMed Central  Google Scholar 

Omran D, Al Soda M, Bahbah E et al (2021) Predictors of severity and development of critical illness of Egyptian COVID-19 patients: a multicenter study. PLoS One 16(9):e0256203

Article  CAS  PubMed  PubMed Central  Google Scholar 

Omran D, Alboraie M, Zayed RA et al (2018) Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol 24(38):4330–4340. https://doi.org/10.3748/wjg.v24.i38.4330

Article  PubMed  PubMed Central  Google Scholar 

Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. https://doi.org/10.1001/jama.2020.4683

"Outbreak brief 124: Coronavirus disease 2019 (COVID-19) pandemic". Africa CDC. 2022. p. 4. Retrieved 7 June 2022.

Peiris JS, Chu CM, Cheng VC et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perlman S, Netland J (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7:439–450. https://doi.org/10.1038/nrmicro2147

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramadan HK-A, Mahmoud MA, Aburahma MZ et al (2020) Predictors of severity and co-infection resistance profile in COVID-19 patients: first report from Upper Egypt. Infect Drug Resist 13:3409–3422

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ranzani OT, Bastos LSL, Gelli JGM et al (2021) Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med 9:407–418

Article  CAS